These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 7711502)

  • 1. Pretibial myxedema and high-dose intravenous immunoglobulin treatment.
    Antonelli A; Navarranne A; Palla R; Alberti B; Saracino A; Mestre C; Roger P; Agostini S; Baschieri L
    Thyroid; 1994; 4(4):399-408. PubMed ID: 7711502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of high-dose intravenous immunoglobulin treatment of patients with pretibial myxedema and Basedow's disease. Preliminary findings].
    Antonelli A; Saracino A; Agostini S; Alberti B; Melosi A; Gambuzza C; Avantaggiato G; Baschieri L
    Clin Ter; 1992 Sep; 141(9 Pt 2):63-8. PubMed ID: 1281765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needles.
    Vannucchi G; Campi I; Covelli D; Forzenigo L; Beck-Peccoz P; Salvi M
    Thyroid; 2013 May; 23(5):626-32. PubMed ID: 23397966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.
    Chang TC; Wu SL; Hsiao YL; Kuo ST; Chien LF; Kuo YF; Change CC; Chang TJ
    Clin Immunol Immunopathol; 1994 Apr; 71(1):113-20. PubMed ID: 8137554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretibial myxedema in a euthyroid patient.
    Anagnostis P; Artzouchaltzi A; Grekou A; Paschou SA; Gerou S; Tzalokostas V
    Hormones (Athens); 2018 Mar; 17(1):133-135. PubMed ID: 29858862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Euthyroid pretibial myxedema.
    Chen JJ; Ladenson PW
    Am J Med; 1987 Feb; 82(2):318-20. PubMed ID: 3812528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of pretibial myxedema (PTM) with topical steroid ointment application with sealing cover (steroid occlusive dressing technique: steroid ODT) in Graves' patients.
    Takasu N; Higa H; Kinjou Y
    Intern Med; 2010; 49(7):665-9. PubMed ID: 20371956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-tibial myxedema: treatment with intralesional corticosteroid.
    Ramos LO; Mattos PC; Figueredo GL; Maia AA; Romero SA
    An Bras Dermatol; 2015; 90(3 Suppl 1):143-6. PubMed ID: 26312698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretibial myxedema as the initial manifestation of Graves' disease.
    Georgala S; Katoulis AC; Georgala C; Katoulis EC; Hatziolou E; Stavrianeas NG
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):380-3. PubMed ID: 12224697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.
    Lohiya S; Lohiya V; Stahl EJ
    Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euthyroid pretibial myxedema and EMO syndrome.
    Senel E; Güleç AT
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Mar; 18(1):21-3. PubMed ID: 19350184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graves' dermopathy on the big toe].
    Couderc E; Cante V; Renaud O; Guillet G
    Ann Dermatol Venereol; 2013 May; 140(5):382-5. PubMed ID: 23663712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of pretibial myxoedema with pentoxifylline].
    Türke B; Balázs C
    Orv Hetil; 2012 Oct; 153(43):1719-22. PubMed ID: 23089171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretibial mucin. Histologic patterns and clinical correlation.
    Somach SC; Helm TN; Lawlor KB; Bergfeld WF; Bass J
    Arch Dermatol; 1993 Sep; 129(9):1152-6. PubMed ID: 8363399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretibial myxedema: pathophysiology and treatment options.
    Fatourechi V
    Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy.
    Imai Y; Odajima R; Shimizu T; Shishiba Y
    Endocrinol Jpn; 1990 Oct; 37(5):749-52. PubMed ID: 1982261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset pretibial myxedema in the absence of ophthalmopathy: a morphologic evolution.
    Omohundro C; Dijkstra JW; Camisa C; Bergfeld WF
    Cutis; 1996 Sep; 58(3):211-4. PubMed ID: 8886536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annularly arranged nodular pretibial myxedema after 7-year treatment of Graves' disease.
    Kishimoto I; Chuyen NTH; Okamoto H
    J Dermatol; 2018 Jan; 45(1):110-111. PubMed ID: 28150342
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
    Sendhil Kumaran M; Dutta P; Sakia U; Dogra S
    Int J Dermatol; 2015 Aug; 54(8):e280-6. PubMed ID: 26019115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.